Oncology
Research Ethicist Joins Winship Cancer Institute
AtlantaRebecca
Pentz, Ph.D., has joined the faculty of the Winship Cancer Institute
(WCI) at Emory University as a professor of Hematology & Oncology in
Research Ethics.
Dr. Pentz comes to WCI from
the University of Texas M.D. Anderson Cancer Center in Houston, where
she was associate professor of Clinical Ethics. She received her Doctorate
of Philosophy in Philosophy from the University of California at Irvine.
Dr. Pentz is a widely published
investigator and author in bioethics. Her research focuses on ethical
issues involved in oncology research, genetic testing, informed consent
and privacy.
Dr. Pentz also sits on various
national research committees, among them: The Central Institutional
Review Board sponsored by the National Cancer Institute; The ChildrenŐs
Oncology Group Ethics Committee; The Cancer Genetics NetworkEthics
Working Group; and The Centers for Disease Control Institutional Review
Board.
"The Winship Cancer Institute
is bringing in some of the most talented and innovative oncology researchers
in the country," said Dr. Pentz. "With the new emphasis on cancer genetics
and genomic medicine, we are seeing new ethical issues for our patients
and investigators. We have the opportunity here to do cutting edge research
that is ethically well-grounded."
"Dr. Pentz is one of the
most highly respected ethicists in the country," said Jonathan Simons,
MD, director of The Winship Cancer Institute. "She has pioneered some
of the leading ethical approaches to improved cancer patient informed
consent, and her research is advancing the standard of care for oncology
healthcare and oncology research."
|